| Product Code: ETC6752088 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to import raloxifene primarily from the USA, India, Japan, Germany, and Belgium. Despite a low concentration with a low Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -7.29%. Furthermore, the growth rate from 2023 to 2024 experienced a significant decline of -13.39%. These figures indicate a challenging market environment for raloxifene imports into China, suggesting potential shifts in market dynamics or demand patterns.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Raloxifene Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Raloxifene Market Revenues & Volume, 2021 & 2031F |
3.3 China Raloxifene Market - Industry Life Cycle |
3.4 China Raloxifene Market - Porter's Five Forces |
3.5 China Raloxifene Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Raloxifene Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Raloxifene Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 China Raloxifene Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 China Raloxifene Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 China Raloxifene Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 China Raloxifene Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Raloxifene Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about osteoporosis and related conditions in China |
4.2.2 Growing aging population in China |
4.2.3 Rising healthcare expenditure and access to healthcare services |
4.2.4 Government initiatives promoting women's health |
4.2.5 Technological advancements in pharmaceutical research and development |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in China |
4.3.2 Competition from alternative treatments and medications |
4.3.3 Limited reimbursement policies for raloxifene in China |
4.3.4 Concerns regarding potential side effects and safety of raloxifene |
4.3.5 Price sensitivity among Chinese consumers |
5 China Raloxifene Market Trends |
6 China Raloxifene Market, By Types |
6.1 China Raloxifene Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Raloxifene Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Raloxifene Market Revenues & Volume, By Antineoplastic, 2021- 2031F |
6.1.4 China Raloxifene Market Revenues & Volume, By Selective Estrogen Receptor Modulators, 2021- 2031F |
6.2 China Raloxifene Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Raloxifene Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.2.3 China Raloxifene Market Revenues & Volume, By Breast Cancer Prevention, 2021- 2031F |
6.3 China Raloxifene Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 China Raloxifene Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 China Raloxifene Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 China Raloxifene Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 China Raloxifene Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.3 China Raloxifene Market Revenues & Volume, By Capsule, 2021- 2031F |
6.5 China Raloxifene Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Raloxifene Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 China Raloxifene Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Raloxifene Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Raloxifene Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 China Raloxifene Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7 China Raloxifene Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Raloxifene Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 China Raloxifene Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 China Raloxifene Market Revenues & Volume, By , 2021- 2031F |
7 China Raloxifene Market Import-Export Trade Statistics |
7.1 China Raloxifene Market Export to Major Countries |
7.2 China Raloxifene Market Imports from Major Countries |
8 China Raloxifene Market Key Performance Indicators |
8.1 Number of osteoporosis cases diagnosed annually in China |
8.2 Percentage of aging population prescribed raloxifene |
8.3 Adoption rate of raloxifene in different regions of China |
8.4 Patient adherence and compliance rates with raloxifene treatment |
8.5 Number of healthcare facilities offering raloxifene treatment and services |
9 China Raloxifene Market - Opportunity Assessment |
9.1 China Raloxifene Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Raloxifene Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Raloxifene Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 China Raloxifene Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 China Raloxifene Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 China Raloxifene Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Raloxifene Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Raloxifene Market - Competitive Landscape |
10.1 China Raloxifene Market Revenue Share, By Companies, 2024 |
10.2 China Raloxifene Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here